摘要
灰指甲(指甲真菌感染)是非常常见的并广泛存在的,但幸好不常致死。近年来,一些功能强大的药物已被引入临床实践,但主要是由于药物在治疗浓度的感染部位的渗透的难度,这些感染仍然很难治愈。本综述讨论了该病的性质、致病真菌、用于治疗这种疾病的药物的特点。
关键词: 抗真菌药物,灰指甲,皮肤癣菌,灰黄霉素,唑类,多烯大环内酯类,烯丙基胺,环吡酮胺,tavaborole,茶树油。
Current Medicinal Chemistry
Title:Onychomycosis and its Chemotherapy
Volume: 23 Issue: 16
Author(s): Anwer Basha, Fatima Basha, Syed K. Ali, Paul R. Hanson, Berl R. Oakley, Heather Hajovsky, Lester A. Mitscher
Affiliation:
关键词: 抗真菌药物,灰指甲,皮肤癣菌,灰黄霉素,唑类,多烯大环内酯类,烯丙基胺,环吡酮胺,tavaborole,茶树油。
摘要: Onychomycosis (fungal nail infections) is very common worldwide but is fortunately not often lethal. Several powerful drugs have been introduced into clinical practice in recent years, but these infections remain difficult to cure primarily due to the difficulty of penetration of drug to the site of the infection in therapeutic concentrations. The nature of the disease, the causative fungi, and the characteristics of the drugs employed to treat this condition are discussed in this review.
Export Options
About this article
Cite this article as:
Anwer Basha, Fatima Basha, Syed K. Ali, Paul R. Hanson, Berl R. Oakley, Heather Hajovsky, Lester A. Mitscher , Onychomycosis and its Chemotherapy, Current Medicinal Chemistry 2016; 23 (16) . https://dx.doi.org/10.2174/0929867323666160411130103
DOI https://dx.doi.org/10.2174/0929867323666160411130103 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
How to Measure Exercise Performance
Current Respiratory Medicine Reviews The Role of Topical Growth Factors in Chronic Wounds
Current Drug Delivery Targeted Therapies in Hepatocellular Carcinoma
Current Medicinal Chemistry Hypoxia Responsive Drug Delivery Systems in Tumor Therapy
Current Pharmaceutical Design Role, Function and Therapeutic Potential of microRNAs in Vascular Aging
Current Vascular Pharmacology Pharmacology of the Human Saphenous Vein
Current Vascular Pharmacology Chronic Kidney Disease and Thrombosis
Current Pediatric Reviews Current Status of Pharmacological Thrombolytic Therapy and Mechanical Thrombectomy for the Treatment of Acute Deep Venous Thrombosis
Cardiovascular & Hematological Agents in Medicinal Chemistry Prevention and Treatment of Venous Thromboembolism and Pulmonary Embolism: The Role of Novel Oral Anticoagulants
Current Clinical Pharmacology Hypoxia-Inducible Factor-1 (HIF-1): A Potential Target for Intervention in Ocular Neovascular Diseases
Current Drug Targets Pharmacogenetic Aspects in Therapeutic Management of Subfoveal Choroidal Neovascularisation: Role of Factor XIII-A 185 T-Allele
Current Drug Targets The Crosstalk of RAS with the TGF-β Family During Carcinoma Progression and its Implications for Targeted Cancer Therapy
Current Cancer Drug Targets Human Mesenchymal Stem Cells Increases Expression of α-Tubulin and Angiopoietin 1 and 2 in Focal Cerebral Ischemia and Reperfusion
Current Neurovascular Research The Influence of DMPK as an Integrated Partner in Modern Drug Discovery
Current Drug Metabolism Endovascular Repair of Thoracic Aortic Aneurysms
Recent Patents on Cardiovascular Drug Discovery Treatment of Hypertensive Complications in Pregnancy
Current Pharmaceutical Design Neurovascular Mechanisms of Hypertension in Pregnancy
Current Neurovascular Research Placental Cytokines in the Pathogenesis of Preeclampsia and Hellp Syndrome
Current Women`s Health Reviews A Contemporary Approach to Macular Edema Treatment in Retinal Vein Occlusion
Vascular Disease Prevention (Discontinued) Perioperative Thromboprophylaxis and Anticoagulation in Patients Undergoing Non-Cardiac Vascular Surgery
Current Vascular Pharmacology